Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy

Neuroradiology

Volumn 47, Issue 1, 2005, Pages 27-34

  Mechtcheriakov, Sergei ^a   Schocke, Michael ^a   Kugener, André ^a   Graziadei, Ivo W ^a   Mattedi, Michael ^a   Hinterhuber, Hartmann ^a   Vogel, Wolfgang ^a   Marksteiner, Josef ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Choline; Cingulate gyrus; Magnetic resonance spectroscopy; Minimal hepatic encephalopathy; N acetyl N aspartate; Visuo motor function

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN DYSFUNCTION; BRAIN LEVEL; BRAIN METABOLISM; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GRAY MATTER; HEPATIC ENCEPHALOPATHY; HUMAN; IMAGE ANALYSIS; LIVER CIRRHOSIS; MALE; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SYMPTOMATOLOGY; VISUOMOTOR COORDINATION; WHITE MATTER;

ASPARTIC ACID; CEREBRAL CORTEX; CHOLINE; CREATININE; FEMALE; GLUTAMIC ACID; GLUTAMINE; GYRUS CINGULI; HEPATIC ENCEPHALOPATHY; HUMANS; INOSITOL; INTELLIGENCE TESTS; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MEMORY; MEMORY, SHORT-TERM; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; TRAIL MAKING TEST;

EID: 13844317797     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-004-1298-8     Document Type: Article

References (40)

1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy - definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716-721
2. Lockwood AH (1998) Early detection and treatment of hepatic encephalopathy Curr Opin Neurol 11:663-666
3. Butterworth RF (2002) Pathophysiology of hepatic encephalopathy: A new look at ammonia. Metab Brain Dis 17:221-227
4. Weissenborn K, Heidenreich S, Giewekemeyer K, Ruckert N, Hecker H (2003) Memory function in early hepatic encephalopathy. J Hepatol 39: 320-325
5. Weissenborn K, Heidenreich S, Ennen J, Ruckert N, Hecker H (2001) Attention deficits in minimal hepatic encephalopathy. Metab Brain Dis 16: 13-19
6. Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768-773
7. Groeneweg M, Moerland W, Quero JC, Hop WC, Krabbe PF, Schalm SW (2000) Screening of subclinical hepatic encephalopathy. J Hepatol 32: 748-753
8. Schomerus H, Hamster W (1998) Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 13:361-377
9. Ross BD, Danielsen ER, Bluml S (1996) Proton magnetic resonance spectroscopy: The new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? Dig Dis 14(Suppl 1):30-39
10. Naegele T, Grodd W, Viebahn R, Seeger U, Klose U, Seitz D, Kaiser S, Mader I, Mayer J, Lauchart W, Gregor M, Voigt K (2000) MR imaging and (1)H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology 216:683-691
11. Kreis R, Ross BD, Farrow NA, Ackerman Z (1992) Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR-spectroscopy. Radiology 182:19-27
12. Ross BD, Jacobson S, Villamil F, Korula J, Kreis R, Ernst T, Shonk T, Moats RA (1994) Subclinical hepatic encephalopathy: Proton MR-spectroscopic abnormalities. Radiology 193:457-463
13. Jalan R, Olde Damink SW, Hayes PC, Wardlaw JM (1999) Diagnosis of hepatic encephalopathy: Will in vivo proton MRS play a role? Hepatology 29:1605-1607
14. H Masur 2000 Skalen und Scores in der Neurologie Georg Thieme Verlag Stuttgart 497
15. DL Lezak 1983 Neuropsychological Assessment Oxford University Press New York
16. S Spreen E Strauss 1991 A Compendium of Neuropsychological Tests Oxford University Press New York
17. S Schaaf J Kessler M Grond GR Fink 1992 Memo-Test Beltz Test GmbH Göttingen
18. S Lehrl 1999 Mehrfach-Wortschatz-Intelligenztest Spitta Verlag Berlingen
19. Knight-Scott J, Haley AP, Rossmiller SR, Farace E, Mai VM, Christopher JM, Manning CA, Simnad VI, Siragy HM (2003) Molality as a unit of measure for expressing 1 H MRS brain metabolite concentrations in vivo. Magn Reson Imaging 21:787-797
20. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R (1989) Localized high-resolution proton NMR spectroscopy using stimulated echoes: Initial applications to human brain in vivo. Magn Reson Med 9:79-93 1:CAS:528:DyaL1MXhs12mu70%3D
21. Michaelis T, Merboldt KD, Hanicke W, Gyngell ML, Bruhn H, Frahm J (1991) On the identification of cerebral metabolites in localized 1 H NMR spectra of human brain in vivo. NMR Biomed 4:90-98 1:STN:280:By6A3MrpslY%3D
22. Geissler A, Lock G, Frund R, Held P, Hollerbach S, Andus T, Scholmerich J, Feuerbach S, Holstege A (1997) Cerebral abnormalities in patients with cirrhosis detected by proton magnetic resonance spectroscopy and magnetic resonance imaging. Hepatology 25:48-54
23. Taylor-Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ (1994) Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 9:347-359
24. Cordoba J, Sanpedro F, Alonso J, Rovira A (2002) 1H magnetic resonance in the study of hepatic encephalopathy in humans. Metab Brain Dis 17:415-429
25. Boesch SM, Schocke M, Burk K, Hollosi P, Fornai F, Aichner FT, Poewe W, Felber S (2001) Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6. J Magn Reson Imaging 13:553-559
26. Kantarci K, Reynolds G, Petersen RC, Boeve BF, Knopman DS, Edland SD, Smith GE, Ivnik RJ, Tangalos EG, Jack CR, Jr. (2003) Proton MR-spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3 T. AJNR Am J Neuroradiol 24:843-849
27. Del Sole A, Gambini A, Falini A, Lecchi M, Lucignani G (2002) In vivo neurochemistry with emission tomography and magnetic resonance spectroscopy: Clinical applications. Eur Radiol 12:2582-2599
28. Schocke MFH, Berger T, Felber SR, Wolf C, Deisenhammer F, Kremser C, Seppi K, Aichner FT (2003) Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under high-dose methylprednisolone therapy. Neuroimage Oct 20:1253-1263
29. Mechtcheriakov S, Graziadei IW, Mattedi M, Bodner T, Kugener A, Hinterhuber HH, Marksteiner J, Vogel W (2004) Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation. Liver Trans 10:77-83
30. Pelletier D, Nelson SJ, Grenier D, Lu Y, Genain C, Goodkin DE (2002) 3-D echo planar (1)HMRS imaging in MS: Metabolite comparison from supratentorial vs central brain. Magn Reson Imaging 20:599-606
31. Cordoba J, Hinojosa C, Sampedro F, Alonso J, Rovira A, Quiroga S, Esteban R, Guardia J (2001) Usefulness of magnetic resonance spectroscopy for diagnosis of hepatic encephalopathy in a patient with relapsing confusional syndrome. Dig Dis Sci 46:2451-2455
32. Catafau AM, Kulisevsky J, Berna L, Pujol J, Martin JC, Otermin P, Balanzo J, Carrio I (2000) Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopathy. J Nucl Med 41: 405-410
33. Clarke CE, Lowry M (2001) Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes. Eur J Neurol 8:573-577
34. Monfort P, Munoz MD, ElAyadi A, Kosenko E, Felipo V (2002) Effects of hyperammonemia and liver failure on glutamatergic neurotransmission. Metab Brain Dis 17:237-250
35. Gehl LM, Saab OH, Bzdega T, Wroblewska B, Neale JH (2004) Biosynthesis of NAAG by an enzyme-mediated process in rat central nervous system neurons and glia. J Neurochem 90:989-997
36. Neale JH, Bzdega T, Wroblewska B (2000) N-Acetylaspartylglutamate: The most abundant peptide neurotransmitter in the mammalian central nervous system. J Neurochem 75:443-452
37. Pouwels PJ, Frahm J (1997) Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS. NMR Biomed 10:73-78
38. Tyson RL, Sutherland GR (1998) Labeling of N-acetylaspartate and N-acetylaspartylglutamate in rat neocortex, hippocampus and cerebellum from [1-13C]glucose. Neurosci Lett 251:181-184
39. Tkac I, Dirk Keene, Walter C.Low, Rolf Gruetter, Pierre-Gilles Henry (2004) Highly resolved in vivo 1 H NMR spectroscopy of the mouse brain at 9.4 T. Magn Reson Med 52(3):478-484
40. Rovira A, Grive E, Pedraza S, Rovira A, Alonso J (2001) Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis. AJNR Am J Neuroradiol 22:1137-1142